Corrigendum to “Use of Aripiprazole Long Acting Injection in Negative Symptoms of Schizophrenia”

Corrigendum to “Use of Aripiprazole Long Acting Injection in Negative Symptoms of Schizophrenia”

Bibliographic Details
Main Authors:	Suneeta James, Chaya Kapugama, Mohammed Al-Uzri
Format:	Article
Language:	English
Published:	Hindawi Limited 2019-01-01
Series:	Case Reports in Psychiatry
Online Access:	http://dx.doi.org/10.1155/2019/9595638

Similar Items

Use of Aripiprazole Long Acting Injection in Negative Symptoms of Schizophrenia
by: Suneeta James, et al.
Published: (2016-01-01)

Aripiprazole Long-Acting Injection During First Episode Schizophrenia—An Exploratory Analysis
by: Gloria Giordano, et al.
Published: (2020-01-01)

Long-acting injectable aripiprazole in pregnant women with schizophrenia: a case-series report
by: Blanca Fernández-Abascal, et al.
Published: (2021-01-01)

Online Survey of Clinical Practice in Patients with Schizophrenia Treated with Long-Acting Injectable Aripiprazole or Paliperidone Palmitate
by: Such P, et al.
Published: (2021-06-01)

Aripiprazole Lauroxil, a Novel Injectable Long-Acting Antipsychotic Treatment for Adults with Schizophrenia: A Comprehensive Review
by: Kunal Maini, et al.
Published: (2021-07-01)

The use of concurrent long-acting injectable antipsychotic therapy with paliperidone palmitate and aripiprazole monohydrate in a patient with schizophrenia
by: Anderson, M., et al.
Published: (2021)

Effect of aripiprazole on mismatch negativity (MMN) in schizophrenia.
by: Zhenhe Zhou, et al.
Published: (2013-01-01)

Plasma concentrations and dosing of 2 long-acting injectable formulations of aripiprazole
by: Salzman PM, et al.
Published: (2017-04-01)

Pharmacokinetics and safety of deltoid or gluteal injection of aripiprazole lauroxil NanoCrystal Dispersion used for initiation of the long-acting antipsychotic aripiprazole lauroxil
by: Marjie L. Hard, et al.
Published: (2019-07-01)

Once-Monthly Long-Acting Injectable Aripiprazole for the Treatment of Patients with Schizophrenia and Co-occurring Substance Use Disorders: A Multicentre, Observational Study
by: Nestor Szerman, et al.
Published: (2020-02-01)

Schizophrenia relapse and the clinical usefulness of once-monthly aripiprazole depot injection
by: Wang SM, et al.
Published: (2014-08-01)

Effectiveness of 2-year treatment with aripiprazole long-acting injectable and comparison with paliperidone palmitate
by: Katy Mason, et al.
Published: (2021-07-01)

The effectiveness of long-term aripiprazole injections to a patient with paranoid schizophrenia: a case report
by: Szota Anna Maria, et al.
Published: (2020-09-01)

Evaluating the cost and clinical effectiveness of long-acting, injectable aripiprazole and paliperidone palmitate once a month in a real-world setting [Corrigendum]
by: Hodgson RE
Published: (2019-09-01)

Correction to: Once‑Monthly Long‑Acting Injectable Aripiprazole for the Treatment of Patients with Schizophrenia and Co‑occurring Substance Use Disorders: A Multicentre, Observational Study
by: Nestor Szerman, et al.
Published: (2020-02-01)

The clinical utility of serum level of Aripiprazole and Dehydro-aripiprazole in schizophrenia
by: Hui-Hsin Chuang, et al.
Published: (2016)

Pharmacogenetic evaluation to assess breakthrough psychosis with aripiprazole long-acting injection: a case report
by: Seenae Eum, et al.
Published: (2017-07-01)

Aripiprazole for late-life schizophrenia
by: Jeffrey Rado, et al.
Published: (2010-08-01)

Review of depot aripiprazole for schizophrenia
by: Motiwala FB, et al.
Published: (2013-11-01)

Use of long acting injectable aripiprazole before and through pregnancy in bipolar disorder: a case report
by: Isabel Ballester-Gracia, et al.
Published: (2019-08-01)

The Use of Long-Acting Injectable Antipsychotic Therapy for Schizophrenia
by: Jason Jiang, et al.
Published: (2018-09-01)

Semantic memory deficit in schizophrenia
by: Al-Uzri, Mohammed M.
Published: (2009)

Role of aripiprazole in treatment-resistant schizophrenia
by: Mossaheb N, et al.
Published: (2012-05-01)

Cost/effectiveness of aripiprazole vs. olanzapine in the long-term treatment of schizophrenia
by: Dutina Aleksandra, et al.
Published: (2019-01-01)

Long-Acting Injectable Antipsychotics in First-Episode Schizophrenia
by: Eduard Parellada, et al.
Published: (2012-01-01)

Aripiprazole worsening positive symptoms and memantine reducing negative symptoms in a patient with paranoid schizophrenia Aripiprazol piorando os sintomas positivos e memantina reduzindo os sintomas negativos em um paciente com esquizofrenia paranóide
by: Milena Pereira Pondé, et al.
Published: (2007-03-01)

Aripiprazole-associated tic in a schizophrenia patient
by: Guo X, et al.
Published: (2015-03-01)

Mania/hipomania induzida por aripiprazol Manic/hypomanic symptoms induced by aripiprazole
by: Márcio Gerhardt Soeiro de Souza, et al.
Published: (2010-01-01)

Patient perspectives in the development and use of long-acting antipsychotics in schizophrenia: focus on olanzapine long-acting injection
by: Leslie Citrome
Published: (2009-11-01)

Patient and Health Care Provider Perspectives on Long Acting Injectable Antipsychotics in Schizophrenia and the Introduction of Olanzapine Long-Acting Injection
by: Heidi J. Wehring, et al.
Published: (2011-01-01)

Patient and Health Care Provider Perspectives on Long Acting Injectable Antipsychotics in Schizophrenia and the Introduction of Olanzapine Long-Acting Injection
by: Heidi J. Wehring, et al.
Published: (2011-06-01)

Using Extended-Release Injectable Aripiprazole for the Successful Treatment of Depressive Symptoms in Bipolar I Disorder
by: Joseph Kuo, et al.
Published: (2020-01-01)

Long-Acting Injectable Drugs in the Maintenance Therapy of Patients with Schizophrenia
by: Natalia N. Petrova, et al.
Published: (2020-12-01)

Long-term effect of aripiprazole lauroxil on health-related quality of life in patients with schizophrenia
by: Joseph P. McEvoy, et al.
Published: (2021-03-01)

Spotlight on once-monthly long-acting injectable aripiprazole and its potential as maintenance treatment for bipolar I disorder in adult patients
by: Torres-Llenza V, et al.
Published: (2018-01-01)

Negative symptoms in schizophrenia
by: Sayantanava Mitra, et al.
Published: (2016-01-01)

Schizophrenia symptoms and functioning in patients receiving long-term treatment with olanzapine long-acting injection formulation: a pooled analysis
by: Peuskens Joseph, et al.
Published: (2012-08-01)

Corrigendum: Positive and Negative Symptoms in Schizophrenia Relate to Distinct Oscillatory Signatures of Sensory Gating
by: Julian eKeil, et al.
Published: (2016-04-01)

Effect of aripiprazole and olanzapine on the cognitive function in patients with schizophrenia
by: Xiao-Hong Wang
Published: (2020-05-01)

Aripiprazole for refractory catatonic schizophrenia – A case report
by: Saisudha N V Gorthi, et al.
Published: (2015-01-01)

Cannot write session to /tmp/vufind_sessions/sess_nj7fk7qrh13r1adv3jf6ta4q3g